Benign Prostatic Hyperplasia

Investigators: Consider 5-ARI Use When Deciding on Prostate Biopsy

Publish Date September 12, 2021

At prostate cancer diagnosis, clinical T stage was significantly higher among 5-ARI users compared with nonusers.

Fewer Complications After Laser Enucleation of the Prostate

Publish Date September 10, 2021

Laser enucleation of the prostate accounts for less than 5% of all BPH procedures performed in the US.

TURP vs Laser Prostatectomy in Older and Multimorbid Men

Publish Date September 10, 2021

Laser prostatectomy included laser coagulation, vaporization, and enucleation of the prostate.

Customized Ablation for Prostate Cancer Offers Favorable Early Results

Publish Date June 18, 2021

Investigators reported an 88% early treatment success rate in 52 men who underwent MRI-guided transurethral ultrasound ablation for localized prostate cancer.

5-ARIs Shown to Benefit Men on Prostate Cancer AS

Publish Date March 18, 2021

Men who take 5-alpha-reductase inhibitors while on active surveillance for prostate cancer are less likely to experience cancer progression, according to a new study

Certain Prostate Drugs Tied to Risk for Parkinson Disease

Publish Date March 5, 2021

Use of glycolysis-enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin

BPH Medications May Increase Heart Failure Risk

Publish Date March 4, 2021

It is important for urologists and primary care physicians to be aware of the potential link between BPH medications and heart failure risk, according to investigators.

TURP Superior to Prostatic Artery Embolization at Improving BPH Symptoms

Publish Date February 24, 2021

At 24 months after treatment for refractory BPH symptoms, patients who underwent transurethral resection of the prostate had more pronounced improvements in most functional outcomes compared with those treated with prostatic artery embolization, a study found.

Adding Vibegron to BPH Meds Safe, Effective for Overactive Bladder

Publish Date February 8, 2021

In a small study, add-on vibegron appeared well-tolerated and clinically effective among men with persistent OAB.

Combination Therapy More Effective for BPH-Induced Overactive Bladder

Publish Date January 26, 2021

A meta-analysis evaluated the efficacy and safety of imidafenacin for overactive bladder induced by benign prostatic hyperplasia.